138 related articles for article (PubMed ID: 9116178)
21. Relationships between clinical symptoms and monoamine metabolite concentrations in biochemically defined subgroups of depressed patients.
Nordin C
Acta Psychiatr Scand; 1988 Dec; 78(6):720-9. PubMed ID: 2464903
[TBL] [Abstract][Full Text] [Related]
22. The effect of lumbar puncture stress on dopamine and serotonin metabolites in human cerebrospinal fluid.
Hill KK; West SA; Ekhator NN; Bruce AB; Wortman MD; Baker DG; Geracioti TD
Neurosci Lett; 1999 Nov; 276(1):25-8. PubMed ID: 10586966
[TBL] [Abstract][Full Text] [Related]
23. Cerebrospinal fluid monoamine metabolite concentrations in depressive disorder: A meta-analysis of historic evidence.
Ogawa S; Tsuchimine S; Kunugi H
J Psychiatr Res; 2018 Oct; 105():137-146. PubMed ID: 30219563
[TBL] [Abstract][Full Text] [Related]
24. Monoamine metabolites in CSF and suicidal behavior.
Träskman L; Asberg M; Bertilsson L; Sjöstrand L
Arch Gen Psychiatry; 1981 Jun; 38(6):631-6. PubMed ID: 6166274
[TBL] [Abstract][Full Text] [Related]
25. No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals.
Hjärpe J; Söderman E; Andreou D; Sedvall GC; Agartz I; Jönsson EG
Psychiatry Res; 2018 May; 263():30-34. PubMed ID: 29482043
[TBL] [Abstract][Full Text] [Related]
26. Decreased monoamine metabolites in frontotemporal dementia and Alzheimer's disease.
Sjögren M; Minthon L; Passant U; Blennow K; Wallin A
Neurobiol Aging; 1998; 19(5):379-84. PubMed ID: 9880039
[TBL] [Abstract][Full Text] [Related]
27. Genetics of monoamine metabolites in baboons: overlapping sets of genes influence levels of 5-hydroxyindolacetic acid, 3-hydroxy-4-methoxyphenylglycol, and homovanillic acid.
Rogers J; Martin LJ; Comuzzie AG; Mann JJ; Manuck SB; Leland M; Kaplan JR
Biol Psychiatry; 2004 Apr; 55(7):739-44. PubMed ID: 15039003
[TBL] [Abstract][Full Text] [Related]
28. Monoamine metabolites in 'leftover' newborn human cerebrospinal fluid--a potential resource for biobehavioral research.
Constantino JN; Murphy DL
Psychiatry Res; 1996 Dec; 65(3):129-42. PubMed ID: 9029662
[TBL] [Abstract][Full Text] [Related]
29. Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome.
Eriksson E; Alling C; Andersch B; Andersson K; Berggren U
Neuropsychopharmacology; 1994 Nov; 11(3):201-13. PubMed ID: 7532413
[TBL] [Abstract][Full Text] [Related]
30. Stability of monoamine metabolites in human cerebrospinal fluid.
Langlais PJ; Bird ED; McEntee WJ
Ann Neurol; 1982 Jul; 12(1):48-51. PubMed ID: 6180677
[TBL] [Abstract][Full Text] [Related]
31. Monoamine metabolites in cerebrospinal fluid during and after acute cerebral ischemia.
Tang HZ; Lu XF; Wang KJ; Ouyang S; Huang YQ
Mol Chem Neuropathol; 1989 Apr; 10(2):77-85. PubMed ID: 2472800
[TBL] [Abstract][Full Text] [Related]
32. Intercorrelations among monoamine metabolite concentrations in human lumbar CSF are not due to a shared acid transport system.
Jibson M; Faull KF; Csernansky JG
Biol Psychiatry; 1990 Oct; 28(7):595-602. PubMed ID: 1699614
[TBL] [Abstract][Full Text] [Related]
33. Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls.
Oreland L; Wiberg A; Asberg M; Träskman L; Sjöstrand L; Thorén P; Bertilsson L; Tybring G
Psychiatry Res; 1981 Feb; 4(1):21-9. PubMed ID: 6164071
[TBL] [Abstract][Full Text] [Related]
34. CSF monoamine metabolites in schizophrenic patients.
Gattaz WF; Waldmeier P; Beckmann H
Acta Psychiatr Scand; 1982 Nov; 66(5):350-60. PubMed ID: 6184954
[TBL] [Abstract][Full Text] [Related]
35. Aberrant monoamine metabolite levels in CSF and family history of schizophrenia. Their relationships in schizophrenic patients.
Sedvall GC; Wode-Helgodt B
Arch Gen Psychiatry; 1980 Oct; 37(10):1113-6. PubMed ID: 6158928
[TBL] [Abstract][Full Text] [Related]
36. Concentrations of monoamine metabolites in human lumbar and cisternal cerebrospinal fluid.
Johansson B; Roos BE
Acta Neurol Scand; 1975 Aug; 52(2):137-44. PubMed ID: 1155031
[TBL] [Abstract][Full Text] [Related]
37. Neuropsychological test performance and CSF levels of monoamine metabolites in healthy volunteers and patients with Alzheimer's dementia.
Nybäck H; Nyman H; Schalling D
Acta Psychiatr Scand; 1987 Dec; 76(6):648-56. PubMed ID: 2450445
[TBL] [Abstract][Full Text] [Related]
38. Cerebrospinal fluid levels of monoamine compounds and cholecystokinin peptides after exposure to standardized barometric pressure.
Eklundh T; Gunnarsson T; Ornhagen H; Nordin C
Aviat Space Environ Med; 2000 Nov; 71(11):1131-6. PubMed ID: 11086668
[TBL] [Abstract][Full Text] [Related]
39. Homicide, suicide and CSF 5-HIAA.
Lidberg L; Tuck JR; Asberg M; Scalia-Tomba GP; Bertilsson L
Acta Psychiatr Scand; 1985 Mar; 71(3):230-6. PubMed ID: 2580421
[TBL] [Abstract][Full Text] [Related]
40. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
Carpenter LL; Moreno FA; Kling MA; Anderson GM; Regenold WT; Labiner DM; Price LH
Biol Psychiatry; 2004 Sep; 56(6):418-26. PubMed ID: 15364040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]